Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1993 Jun;91(6):2769–2775. doi: 10.1172/JCI116518

Quantitation of human immunodeficiency virus, immune activation factors, and quinolinic acid in AIDS brains.

C L Achim 1, M P Heyes 1, C A Wiley 1
PMCID: PMC443343  PMID: 8514884

Abstract

HIV encephalitis is unusual in that neurologic damage occurs in the absence of significant infection of neuronal or glial cells. Because the predominant infected cell in the brain is the macrophage, it has been proposed that release of viral or immune activation factors from macrophages may mediate neurologic damage. Numerous studies have examined the concentration of immune activation factors in the cerebrospinal fluid (CSF), however, there has been no correlation between these CSF measurements and severity of HIV encephalitis (Wiley, C.A., C.L. Achim, R.D. Schrier, M.P. Heyes, J.A. McCutchen, and I. Grant. 1992. AIDS (Phila.). 6:1299-1307. Because CSF measurements may not represent tissue concentrations of these factors, we examined the concentrations of HIV p24, quinolinic acid (QUIN), IL-1, IL-3, IL-6, TNF-alpha, and GMCSF within the brains of 10 AIDS autopsies. Homogenization and extraction of cortical gray, cortical white and deep gray matter showed a good correlation between the amount of HIV gp41 immunostaining and extracted HIV gag protein p24. The concentrations of cytokines were low in the tissue extracts and showed no correlation with severity of HIV encephalitis. Brain extracts from mild cases of HIV encephalitis showed elevated levels of TNF-alpha in deep gray matter, while in more severe cases, elevated TNF-alpha levels were also found within cortical white and cortical gray matter. Brain tissue and CSF QUIN concentrations were substantially increased compared to control values. QUIN concentrations were not correlated with the severity of HIV encephalitis. We conclude that increased tissue levels of TNF-alpha and QUIN may have a role in the etiology of HIV-related neurologic dysfunction.

Full text

PDF
2769

Images in this article

2772Image
on p.2772
2772Image
on p.2772
2772Image
on p.2772

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Achim C. L., Morey M. K., Wiley C. A. Expression of major histocompatibility complex and HIV antigens within the brains of AIDS patients. AIDS. 1991 May;5(5):535–541. doi: 10.1097/00002030-199105000-00009. [DOI] [PubMed] [Google Scholar]
  2. Anders K. H., Guerra W. F., Tomiyasu U., Verity M. A., Vinters H. V. The neuropathology of AIDS. UCLA experience and review. Am J Pathol. 1986 Sep;124(3):537–558. [PMC free article] [PubMed] [Google Scholar]
  3. Breder C. D., Dinarello C. A., Saper C. B. Interleukin-1 immunoreactive innervation of the human hypothalamus. Science. 1988 Apr 15;240(4850):321–324. doi: 10.1126/science.3258444. [DOI] [PubMed] [Google Scholar]
  4. Brenneman D. E., Westbrook G. L., Fitzgerald S. P., Ennist D. L., Elkins K. L., Ruff M. R., Pert C. B. Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide. Nature. 1988 Oct 13;335(6191):639–642. doi: 10.1038/335639a0. [DOI] [PubMed] [Google Scholar]
  5. Budka H. Human immunodeficiency virus (HIV) envelope and core proteins in CNS tissues of patients with the acquired immune deficiency syndrome (AIDS). Acta Neuropathol. 1990;79(6):611–619. doi: 10.1007/BF00294238. [DOI] [PubMed] [Google Scholar]
  6. Budka H. The definition of HIV-specific neuropathology. Acta Pathol Jpn. 1991 Mar;41(3):182–191. doi: 10.1111/j.1440-1827.1991.tb01645.x. [DOI] [PubMed] [Google Scholar]
  7. Budka H., Wiley C. A., Kleihues P., Artigas J., Asbury A. K., Cho E. S., Cornblath D. R., Dal Canto M. C., DeGirolami U., Dickson D. HIV-associated disease of the nervous system: review of nomenclature and proposal for neuropathology-based terminology. Brain Pathol. 1991 Apr;1(3):143–152. doi: 10.1111/j.1750-3639.1991.tb00653.x. [DOI] [PubMed] [Google Scholar]
  8. Cotman C. W., Monaghan D. T. Anatomical organization of excitatory amino acid receptors and their properties. Adv Exp Med Biol. 1986;203:237–252. doi: 10.1007/978-1-4684-7971-3_18. [DOI] [PubMed] [Google Scholar]
  9. Davis L. E., Hjelle B. L., Miller V. E., Palmer D. L., Llewellyn A. L., Merlin T. L., Young S. A., Mills R. G., Wachsman W., Wiley C. A. Early viral brain invasion in iatrogenic human immunodeficiency virus infection. Neurology. 1992 Sep;42(9):1736–1739. doi: 10.1212/wnl.42.9.1736. [DOI] [PubMed] [Google Scholar]
  10. Gabuzda D. H., Ho D. D., de la Monte S. M., Hirsch M. S., Rota T. R., Sobel R. A. Immunohistochemical identification of HTLV-III antigen in brains of patients with AIDS. Ann Neurol. 1986 Sep;20(3):289–295. doi: 10.1002/ana.410200304. [DOI] [PubMed] [Google Scholar]
  11. Giulian D., Vaca K., Noonan C. A. Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1. Science. 1990 Dec 14;250(4987):1593–1596. doi: 10.1126/science.2148832. [DOI] [PubMed] [Google Scholar]
  12. Heyes M. P., Brew B. J., Martin A., Price R. W., Salazar A. M., Sidtis J. J., Yergey J. A., Mouradian M. M., Sadler A. E., Keilp J. Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status. Ann Neurol. 1991 Feb;29(2):202–209. doi: 10.1002/ana.410290215. [DOI] [PubMed] [Google Scholar]
  13. Heyes M. P., Brew B. J., Saito K., Quearry B. J., Price R. W., Lee K., Bhalla R. B., Der M., Markey S. P. Inter-relationships between quinolinic acid, neuroactive kynurenines, neopterin and beta 2-microglobulin in cerebrospinal fluid and serum of HIV-1-infected patients. J Neuroimmunol. 1992 Sep;40(1):71–80. doi: 10.1016/0165-5728(92)90214-6. [DOI] [PubMed] [Google Scholar]
  14. Heyes M. P., Jordan E. K., Lee K., Saito K., Frank J. A., Snoy P. J., Markey S. P., Gravell M. Relationship of neurologic status in macaques infected with the simian immunodeficiency virus to cerebrospinal fluid quinolinic acid and kynurenic acid. Brain Res. 1992 Jan 20;570(1-2):237–250. doi: 10.1016/0006-8993(92)90587-y. [DOI] [PubMed] [Google Scholar]
  15. Heyes M. P., Markey S. P. Quantification of quinolinic acid in rat brain, whole blood, and plasma by gas chromatography and negative chemical ionization mass spectrometry: effects of systemic L-tryptophan administration on brain and blood quinolinic acid concentrations. Anal Biochem. 1988 Oct;174(1):349–359. doi: 10.1016/0003-2697(88)90556-8. [DOI] [PubMed] [Google Scholar]
  16. Heyes M. P., Nowak T. S., Jr Delayed increases in regional brain quinolinic acid follow transient ischemia in the gerbil. J Cereb Blood Flow Metab. 1990 Sep;10(5):660–667. doi: 10.1038/jcbfm.1990.119. [DOI] [PubMed] [Google Scholar]
  17. Heyes M. P., Saito K., Crowley J. S., Davis L. E., Demitrack M. A., Der M., Dilling L. A., Elia J., Kruesi M. J., Lackner A. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease. Brain. 1992 Oct;115(Pt 5):1249–1273. doi: 10.1093/brain/115.5.1249. [DOI] [PubMed] [Google Scholar]
  18. Heyes M. P., Saito K., Jacobowitz D., Markey S. P., Takikawa O., Vickers J. H. Poliovirus induces indoleamine-2,3-dioxygenase and quinolinic acid synthesis in macaque brain. FASEB J. 1992 Aug;6(11):2977–2989. doi: 10.1096/fasebj.6.11.1322853. [DOI] [PubMed] [Google Scholar]
  19. Heyes M. P., Saito K., Markey S. P. Human macrophages convert L-tryptophan into the neurotoxin quinolinic acid. Biochem J. 1992 May 1;283(Pt 3):633–635. doi: 10.1042/bj2830633. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Koenig S., Gendelman H. E., Orenstein J. M., Dal Canto M. C., Pezeshkpour G. H., Yungbluth M., Janotta F., Aksamit A., Martin M. A., Fauci A. S. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science. 1986 Sep 5;233(4768):1089–1093. doi: 10.1126/science.3016903. [DOI] [PubMed] [Google Scholar]
  21. Levy R. M., Bredesen D. E., Rosenblum M. L. Neurological manifestations of the acquired immunodeficiency syndrome (AIDS): experience at UCSF and review of the literature. J Neurosurg. 1985 Apr;62(4):475–495. doi: 10.3171/jns.1985.62.4.0475. [DOI] [PubMed] [Google Scholar]
  22. Martin A., Heyes M. P., Salazar A. M., Kampen D. L., Williams J., Law W. A., Coats M. E., Markey S. P. Progressive slowing of reaction time and increasing cerebrospinal fluid concentrations of quinolinic acid in HIV-infected individuals. J Neuropsychiatry Clin Neurosci. 1992 Summer;4(3):270–279. doi: 10.1176/jnp.4.3.270. [DOI] [PubMed] [Google Scholar]
  23. Masliah E., Ge N., Morey M., DeTeresa R., Terry R. D., Wiley C. A. Cortical dendritic pathology in human immunodeficiency virus encephalitis. Lab Invest. 1992 Mar;66(3):285–291. [PubMed] [Google Scholar]
  24. Meltzer M. S., Nakamura M., Hansen B. D., Turpin J. A., Kalter D. C., Gendelman H. E. Macrophages as susceptible targets for HIV infection, persistent viral reservoirs in tissue, and key immunoregulatory cells that control levels of virus replication and extent of disease. AIDS Res Hum Retroviruses. 1990 Aug;6(8):967–971. doi: 10.1089/aid.1990.6.967. [DOI] [PubMed] [Google Scholar]
  25. Molina J. M., Schindler R., Ferriani R., Sakaguchi M., Vannier E., Dinarello C. A., Groopman J. E. Production of cytokines by peripheral blood monocytes/macrophages infected with human immunodeficiency virus type 1 (HIV-1). J Infect Dis. 1990 May;161(5):888–893. doi: 10.1093/infdis/161.5.888. [DOI] [PubMed] [Google Scholar]
  26. Navia B. A., Cho E. S., Petito C. K., Price R. W. The AIDS dementia complex: II. Neuropathology. Ann Neurol. 1986 Jun;19(6):525–535. doi: 10.1002/ana.410190603. [DOI] [PubMed] [Google Scholar]
  27. Navia B. A., Jordan B. D., Price R. W. The AIDS dementia complex: I. Clinical features. Ann Neurol. 1986 Jun;19(6):517–524. doi: 10.1002/ana.410190602. [DOI] [PubMed] [Google Scholar]
  28. Price R. W., Sidtis J. J., Brew B. J. AIDS dementia complex and HIV-1 infection: a view from the clinic. Brain Pathol. 1991 Apr;1(3):155–162. doi: 10.1111/j.1750-3639.1991.tb00655.x. [DOI] [PubMed] [Google Scholar]
  29. Pulliam L., Herndier B. G., Tang N. M., McGrath M. S. Human immunodeficiency virus-infected macrophages produce soluble factors that cause histological and neurochemical alterations in cultured human brains. J Clin Invest. 1991 Feb;87(2):503–512. doi: 10.1172/JCI115024. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Saito K., Nowak T. S., Jr, Markey S. P., Heyes M. P. Mechanism of delayed increases in kynurenine pathway metabolism in damaged brain regions following transient cerebral ischemia. J Neurochem. 1993 Jan;60(1):180–192. doi: 10.1111/j.1471-4159.1993.tb05836.x. [DOI] [PubMed] [Google Scholar]
  31. Tyor W. R., Glass J. D., Griffin J. W., Becker P. S., McArthur J. C., Bezman L., Griffin D. E. Cytokine expression in the brain during the acquired immunodeficiency syndrome. Ann Neurol. 1992 Apr;31(4):349–360. doi: 10.1002/ana.410310402. [DOI] [PubMed] [Google Scholar]
  32. Whetsell W. O., Jr, Schwarcz R. Prolonged exposure to submicromolar concentrations of quinolinic acid causes excitotoxic damage in organotypic cultures of rat corticostriatal system. Neurosci Lett. 1989 Feb 27;97(3):271–275. doi: 10.1016/0304-3940(89)90609-5. [DOI] [PubMed] [Google Scholar]
  33. Wiley C. A., Achim C. L., Schrier R. D., Heyes M. P., McCutchan J. A., Grant I. Relationship of cerebrospinal fluid immune activation associated factors to HIV encephalitis. AIDS. 1992 Nov;6(11):1299–1307. doi: 10.1097/00002030-199211000-00010. [DOI] [PubMed] [Google Scholar]
  34. Wiley C. A., Masliah E., Morey M., Lemere C., DeTeresa R., Grafe M., Hansen L., Terry R. Neocortical damage during HIV infection. Ann Neurol. 1991 Jun;29(6):651–657. doi: 10.1002/ana.410290613. [DOI] [PubMed] [Google Scholar]
  35. Wiley C. A., Nelson J. A. Role of human immunodeficiency virus and cytomegalovirus in AIDS encephalitis. Am J Pathol. 1988 Oct;133(1):73–81. [PMC free article] [PubMed] [Google Scholar]
  36. Wiley C. A., Schrier R. D., Nelson J. A., Lampert P. W., Oldstone M. B. Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc Natl Acad Sci U S A. 1986 Sep;83(18):7089–7093. doi: 10.1073/pnas.83.18.7089. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES